Gauri Godbole, from Public Health England, gives us an overview of recent advances and updates in the field of gastrointestinal infections – from the impact of the microbiome to the growing threat of antimicrobial resistance.
Browsing: Disease Area > Bacterial
A Phase II trial has demonstrated that a new investigational antibiotic, cefiderocol, is as effective as the current standard-of-care for treating complicated UTIs caused by multi-drug resistant bacteria.
Researchers from the Center for Infection and Immunity have made a major breakthrough in diagnoses of pathogenic bacteria with their design, the BacCapSeq platform. It’s the first precision medicine platform to allow simultaneous screening for all known bacterial pathogens, as well as markers for antibiotic resistance and virulence.
In this interview, we spoke to Yoav Golan about recent developments in the field of Clostridium difficile infections – from the latest clinical trial results to newly updated guidelines.
The UK’s Health & Social Care Select Committee has concluded that antimicrobial resistance should be established as a ‘top five policy priority’ for the UK Government.
Small molecules that block bacterial toxin formation have shown promise against Gram-positive bacteria in mouse models.
In this interview we speak to Amy Mathers about her research on the role of hospital plumbing in the evolution and exchange of genes of drug resistance.
Researchers at Stanford University School of Medicine have reported that the most common origin of bloodstream infections, during a hospital stay, as a consequence of the patient’s own gut.
Researchers from Purdue University have reported that antimicrobial photodynamic therapy using a fluorescent analog of heme, could be an alternative for treating MRSA infections.
In this infographic we take a look at the estimated burden of healthcare-associated infections in acute care hospitals across Europe.